• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内 CXCL13CD8T 细胞浸润决定了透明细胞肾细胞癌患者的不良临床结局和免疫逃避结构。

Intratumoral CXCL13CD8T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.

机构信息

Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

出版信息

J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001823.

DOI:10.1136/jitc-2020-001823
PMID:33589528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7887366/
Abstract

BACKGROUND

Chemokine (C-X-C motif) ligand 13 (CXCL13) was known as a selective chemotaxis for B cells, a product of follicular helper CD4T cells (T) and a contributor to tertiary lymphoid structures (TLS). Although secretion and function of CXCL13 produced by T have been deeply explored, the immune function and prognostic significance of CXCL13 secreted by CD8T cells still remain unrevealed. This study aims to investigate the clinical merit of CXCL13CD8T cells in clear cell renal cell carcinoma (ccRCC).

METHODS

We analyzed prognostic value and immune contexture that associated with CXCL13CD8T cells infiltration level in a total of 755 patients from Zhongshan Hospital cohort (n=223) and The Cancer Genome Atlas cohort (n=532). In vitro analyses were conducted on 42 samples of resected tumor tissue from Zhongshan Hospital in order to detect the immune status of CXCL13CD8T cells and total CD8T cells. Immunohistochemistry (IHC) and flow cytometry were applied to characterize immune cells and portray the tumor microenvironment (TME) in ccRCC.

RESULTS

Intratumoral CXCL13CD8T cells abundance was associated with inferior overall survival and disease-free survival. CXCL13CD8T cells possessed higher level of immune checkpoints like programmed cell-death protein 1 (PD-1), T-cell immunoglobulin mucin 3 (Tim-3), T cell immunoreceptor with Ig and ITIM domains (TIGIT) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), higher Ki-67 expression and lower tumor necrosis factor α (TNF-α), interferon γ (IFN-γ) expression. Total CD8T cells in high-level CXCL13CD8T cells infiltration subgroup exhibited elevated exhausted markers (PD-1, Tim-3, TIGIT) and descended activated markers (TNF-α, IFN-γ) without quantity variance. Furthermore, the abundance of intratumoral CXCL13CD8T cell was correlated with immunoevasive TME accompanied by increased T helper 2 cells, tumor-associated macrophages, Foxp3 regulatory T cells, TLS and decreased natural killer cells, GZMB cells.

CONCLUSIONS

Intratumoral CXCL13CD8T cells infiltration indicated inferior clinical outcome in patients with ccRCC. CXCL13CD8T cells possessed increased exhausted markers, decreased effector molecules and better proliferation ability. CXCL13CD8T cells abundance impaired total CD8T cells' immune function. Intratumoral CXCL13CD8T cells abundance was associated with immunoevasive contexture. The abundance of CXCL13CD8T cells was an independent prognosticator and a potential immunotherapeutic target marker for ccRCC treatment.

摘要

背景

趋化因子(C-X-C 基序)配体 13(CXCL13)是一种选择性趋化因子,可吸引 B 细胞,由滤泡辅助 CD4T 细胞(T 细胞)产生,并有助于三级淋巴结构(TLS)的形成。虽然 T 细胞产生的 CXCL13 的分泌和功能已经得到深入研究,但 CD8T 细胞分泌的 CXCL13 的免疫功能和预后意义仍未被揭示。本研究旨在探讨 CXCL13CD8T 细胞在透明细胞肾细胞癌(ccRCC)中的临床价值。

方法

我们分析了来自中山医院队列(n=223)和癌症基因组图谱队列(n=532)的共 755 名患者的预后价值和与 CXCL13CD8T 细胞浸润水平相关的免疫结构。我们对中山医院 42 个切除肿瘤组织样本进行了体外分析,以检测 CXCL13CD8T 细胞和总 CD8T 细胞的免疫状态。免疫组织化学(IHC)和流式细胞术用于描绘 ccRCC 中的免疫细胞和肿瘤微环境(TME)。

结果

肿瘤内 CXCL13CD8T 细胞丰度与总生存率和无病生存率降低相关。CXCL13CD8T 细胞表达更高水平的免疫检查点,如程序性死亡蛋白 1(PD-1)、T 细胞免疫球蛋白粘蛋白 3(Tim-3)、T 细胞免疫受体 Ig 和 ITIM 结构域(TIGIT)和细胞毒性 T 淋巴细胞相关蛋白 4(CTLA-4),Ki-67 表达更高,肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)表达更低。高水平 CXCL13CD8T 细胞浸润亚组中的总 CD8T 细胞表达更高的耗竭标志物(PD-1、Tim-3、TIGIT)和更低的激活标志物(TNF-α、IFN-γ),而细胞数量没有变化。此外,肿瘤内 CXCL13CD8T 细胞的丰度与免疫逃避的 TME 相关,伴有辅助性 T 细胞 2(Th2)细胞、肿瘤相关巨噬细胞、Foxp3 调节性 T 细胞、TLS 增加,自然杀伤细胞、GZMB 细胞减少。

结论

肿瘤内 CXCL13CD8T 细胞浸润与 ccRCC 患者的临床预后不良相关。CXCL13CD8T 细胞具有更高的耗竭标志物表达,更低的效应分子表达和更好的增殖能力。肿瘤内 CXCL13CD8T 细胞的丰度损害了总 CD8T 细胞的免疫功能。肿瘤内 CXCL13CD8T 细胞的丰度与免疫逃避结构有关。CXCL13CD8T 细胞的丰度是 ccRCC 治疗的独立预后因素和潜在的免疫治疗靶点标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/333b483a26f9/jitc-2020-001823f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/cd858508178a/jitc-2020-001823f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/97f0dd07b604/jitc-2020-001823f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/e4f491edc270/jitc-2020-001823f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/407b1b0316e7/jitc-2020-001823f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/333b483a26f9/jitc-2020-001823f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/cd858508178a/jitc-2020-001823f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/97f0dd07b604/jitc-2020-001823f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/e4f491edc270/jitc-2020-001823f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/407b1b0316e7/jitc-2020-001823f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9fe/7887366/333b483a26f9/jitc-2020-001823f05.jpg

相似文献

1
Intratumoral CXCL13CD8T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.肿瘤内 CXCL13CD8T 细胞浸润决定了透明细胞肾细胞癌患者的不良临床结局和免疫逃避结构。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001823.
2
Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.富含 CXCL13+CD8+T 细胞的胃癌患者临床预后不良且免疫逃避。
Oncoimmunology. 2021 Apr 27;10(1):1915560. doi: 10.1080/2162402X.2021.1915560.
3
Tumor-infiltrating CD39CD8 T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.肿瘤浸润 CD39+CD8+T 细胞决定了透明细胞肾细胞癌患者的不良预后和免疫逃逸。
Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576. doi: 10.1007/s00262-020-02563-2. Epub 2020 Apr 18.
4
Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.综合多组学鉴定干扰素-γ反应特征表明 RBCK1 调节肾细胞癌的免疫抑制微环境。
Front Immunol. 2021 Nov 2;12:734646. doi: 10.3389/fimmu.2021.734646. eCollection 2021.
5
Intratumoral TIGIT CD8 T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer.肿瘤内 TIGIT+CD8+T 细胞浸润决定了肌层浸润性膀胱癌患者的不良预后和免疫逃逸。
J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-000978.
6
Tumor-infiltrating TNFRSF9 CD8 T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response.肿瘤浸润性TNFRSF9 CD8 T细胞定义了具有不同预后和免疫治疗反应的透明细胞肾细胞癌亚群。
Oncoimmunology. 2020 Oct 27;9(1):1838141. doi: 10.1080/2162402X.2020.1838141.
7
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13CD103CD8 Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.三级淋巴结构相关 B 细胞增强了趋化因子 CXCL13+CD103+CD8+组织驻留记忆 T 细胞对癌症免疫治疗中程序性细胞死亡蛋白 1 阻断的反应。
Gastroenterology. 2024 Jun;166(6):1069-1084. doi: 10.1053/j.gastro.2023.10.022. Epub 2023 Oct 29.
8
NKG2ACD8 T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma.NKG2ACD8+T 细胞浸润决定了透明细胞肾细胞癌的免疫抑制微环境和对免疫治疗的反应不良。
J Immunother Cancer. 2024 Jan 23;12(1):e008368. doi: 10.1136/jitc-2023-008368.
9
Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.肿瘤内树突状细胞特异性细胞间黏附分子 3 抓取非整联蛋白阳性巨噬细胞导致胃癌免疫逃逸,临床结局较差。
Eur J Cancer. 2020 Mar;128:27-37. doi: 10.1016/j.ejca.2020.01.002. Epub 2020 Mar 5.
10
Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment.己糖激酶 3 功能障碍通过上调单核细胞/巨噬细胞浸润透明细胞肾细胞癌微环境促进肿瘤发生和免疫逃逸。
Int J Biol Sci. 2021 Jun 1;17(9):2205-2222. doi: 10.7150/ijbs.58295. eCollection 2021.

引用本文的文献

1
Identification of kidney renal clear cell carcinoma prognosis based on gene expression and clinical information.基于基因表达和临床信息的肾透明细胞癌预后识别
Front Mol Biosci. 2025 Aug 20;12:1630250. doi: 10.3389/fmolb.2025.1630250. eCollection 2025.
2
The Prediction Model for Triple-Negative Breast Cancer Prognosis and Immunotherapy Efficacy Based on Single-Cell Sequencing of CD8+ T cells.基于CD8+T细胞单细胞测序的三阴性乳腺癌预后及免疫治疗疗效预测模型
J Cancer. 2025 Jul 24;16(11):3343-3354. doi: 10.7150/jca.115507. eCollection 2025.
3
APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer.

本文引用的文献

1
Tumor-infiltrating CD39CD8 T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.肿瘤浸润 CD39+CD8+T 细胞决定了透明细胞肾细胞癌患者的不良预后和免疫逃逸。
Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576. doi: 10.1007/s00262-020-02563-2. Epub 2020 Apr 18.
2
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的综合蛋白质基因组特征分析
Cell. 2020 Jan 9;180(1):207. doi: 10.1016/j.cell.2019.12.026.
3
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
APOE高表达的髓样细胞与原发性肺癌患者经超声支气管镜引导针吸活检术获取的转移性胸内淋巴结具有独特的相关性。
NPJ Precis Oncol. 2025 Aug 20;9(1):292. doi: 10.1038/s41698-025-01091-5.
4
Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment.基于深度学习的透明细胞肾细胞癌自动分割及肿瘤微环境的初步探索
Transl Androl Urol. 2025 Jul 30;14(7):2059-2074. doi: 10.21037/tau-2025-400. Epub 2025 Jul 25.
5
Association of HLA-DRA expression with prognosis and tumor microenvironment in clear cell renal cell carcinoma.HLA-DRA表达与透明细胞肾细胞癌预后及肿瘤微环境的关联
Sci Rep. 2025 Aug 10;15(1):29270. doi: 10.1038/s41598-025-13665-1.
6
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma.全面的肿瘤免疫分析揭示了肉瘤样肾细胞癌中矛盾免疫敏感性的介质。
Cancer Cell. 2025 Jul 23. doi: 10.1016/j.ccell.2025.07.010.
7
NETosis-based prognostic model reveals immune modulation in clear cell renal cell carcinoma using single-cell and bulk RNA sequencing.基于NETosis的预后模型通过单细胞和批量RNA测序揭示透明细胞肾细胞癌中的免疫调节。
Sci Rep. 2025 Jul 25;15(1):27156. doi: 10.1038/s41598-025-11095-7.
8
Epithelial-mesenchymal transition classification based on machine learning for predicting prognosis and treatment response in clear cell renal cell carcinoma.基于机器学习的上皮-间质转化分类用于预测透明细胞肾细胞癌的预后和治疗反应
Transl Androl Urol. 2025 Jun 30;14(6):1742-1758. doi: 10.21037/tau-2025-109. Epub 2025 Jun 26.
9
Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma.干扰素调节因子4招募未成熟B细胞以表明三级淋巴结构的不成熟及透明细胞肾细胞癌的进展。
Int J Biol Sci. 2025 Jun 9;21(9):3827-3851. doi: 10.7150/ijbs.113737. eCollection 2025.
10
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review).超越肿瘤微环境:为下一代癌症免疫疗法协调全身T细胞反应(综述)
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5762. Epub 2025 Jun 13.
透明细胞肾细胞癌的综合蛋白质基因组特征分析。
Cell. 2019 Oct 31;179(4):964-983.e31. doi: 10.1016/j.cell.2019.10.007.
4
Defining 'T cell exhaustion'.定义“T 细胞耗竭”。
Nat Rev Immunol. 2019 Nov;19(11):665-674. doi: 10.1038/s41577-019-0221-9. Epub 2019 Sep 30.
5
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.透明细胞肾细胞癌中的肿瘤微环境动态。
Cancer Discov. 2019 Oct;9(10):1349-1357. doi: 10.1158/2159-8290.CD-19-0499. Epub 2019 Sep 16.
6
Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.通过综合生物信息学分析鉴定 CXCL13 作为透明细胞肾细胞癌的潜在生物标志物。
Biomed Pharmacother. 2019 Oct;118:109264. doi: 10.1016/j.biopha.2019.109264. Epub 2019 Aug 4.
7
Tertiary lymphoid structures in the era of cancer immunotherapy.癌症免疫治疗时代的三级淋巴结构。
Nat Rev Cancer. 2019 Jun;19(6):307-325. doi: 10.1038/s41568-019-0144-6.
8
Transforming Growth Factor-β Signaling in Immunity and Cancer.转化生长因子-β 信号在免疫和癌症中的作用。
Immunity. 2019 Apr 16;50(4):924-940. doi: 10.1016/j.immuni.2019.03.024.
9
A Transcriptionally Distinct CXCL13CD103CD8 T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.一种转录上不同的 CXCL13+CD103+CD8+T 细胞群与人类癌症中的 B 细胞募集和新抗原负荷有关。
Cancer Immunol Res. 2019 May;7(5):784-796. doi: 10.1158/2326-6066.CIR-18-0517. Epub 2019 Mar 14.
10
Immune infiltration in renal cell carcinoma.肾细胞癌中的免疫浸润。
Cancer Sci. 2019 May;110(5):1564-1572. doi: 10.1111/cas.13996. Epub 2019 Apr 7.